Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truvada PrEP in HIV-uninfected lactating women
NCT02776748Phase 3Completed
- Sponsor
- University of Washington
- Start
- Jan 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of emtricitabine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by University of Washington. Started Jan 2015; status: completed.
02
Drugs
emtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02776748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02776748.